CSC restricts antidepressant partly over misuse concerns, but can’t say if issue is widespread
The six-month transition away from bupropion ends Oct. 31, with an advocate saying inmates being offered different drugs report 'feeling like guinea pigs.' Now a coalition of clinicians and advocates are challenging the restrictions on it and ADHD medications, and calling for review.
Correctional Service Canada restricted prisoners’ access to bupropion—a first-choice treatment for depression—on May 1, citing in part reports that some prisoners were crushing, snorting, or injecting the...
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
